
Own
We hold our own dossiers. LHC has registered more than seventy product lines with SAHPRA, from generic statins and antibiotics to specialised therapies for malaria, tuberculosis, and HIV. Twenty-five more dossiers are in active review.
LHC Pharmaceuticals is a registered South African pharmaceutical manufacturer specialising in generic, biosimilar, and innovative medicines, with NEHAWU Investment Holdings as its shareholder. Anchored by an exclusive strategic partnership with KRKA across Southern Africa, LHC stands as one of the largest Black-owned pharmaceutical companies registered with SAHPRA, holding the region's most substantial Black-owned SAHPRA dossier portfolio.

One Health – One Ecosystem
What we do

We hold our own dossiers. LHC has registered more than seventy product lines with SAHPRA, from generic statins and antibiotics to specialised therapies for malaria, tuberculosis, and HIV. Twenty-five more dossiers are in active review.

We move medicine across eight countries. Through a curated channel network of pharmacies and wholesalers, our products reach communities from Pretoria to Luanda to Juba, without the cost or opacity of long intermediary chains.

We close the loop with the patient. Our partnerships with Medipost, Spar Pharmacies, Ekhaya, and other community-rooted retailers put quality medicine within reach of every household we serve.
Portfolio
Footprint
Six markets, with a local partner in each. We don't ship through faceless intermediaries. Every country we operate in has a partner pharmacy, wholesaler, or distributor whose name we can tell you. Specificity is how trust gets built.

Working with
Strategic & equity
Channel partners
Our story
LHC was founded in 2012 by a registered medical practitioner and a pharmacist. They began with a clinical observation, that quality medicine was reaching urban centres but not the communities they trained to serve, and built backward from there. First retail in 2006. Then wholesale and distribution in 2009. Then registration as a SAHPRA Marketing Authorisation Holder in 2012, holding dossiers sourced from reputable manufacturers worldwide. Today LHC is the result of that "end-to-the-beginning" approach: a company that understands the supply chain because it has stood at every point of it.
The work so far
Year founded, Pretoria, South Africa
SADC countries with active distribution
Registered product lines
Dossiers awaiting SAHPRA approval
Quality · Compliance · Care

Every product we distribute in South Africa is registered with the South African Health Products Regulatory Authority. Our pending dossiers, currently more than twenty-five, are tracked publicly through SAHPRA's submission system.
Our flagship contract manufacturing partner is KRKA in Slovenia, whose products are registered in dozens of jurisdictions worldwide. Where KRKA does not manufacture for us, we work with comparably accredited European partners.
Our Linezolid LHC application received Fast-Track status from the regulator, a measure of our submission quality and the public-health value of the molecule for tuberculosis treatment in Southern Africa.
If you're a pharmacy, wholesaler, healthcare professional, or investor, we'd like to hear from you.